Guru Fundamental Report for TMO

Thermo Fisher Scientific (TMO) received a 75% rating from Validea's guru fundamental report under Pim van Vliet's Multi-Factor Investor model, which prioritizes low volatility, strong momentum, and high net payout yields. This score falls short of the 80% threshold for 'some interest' in the strategy, as TMO, despite passing market cap and standard deviation criteria, was neutral on momentum and net payout yield, ultimately resulting in a 'FAIL' for its overall rank within this specific quantitative framework.

Analysis

According to a Validea fundamental report, Thermo Fisher Scientific (TMO) scores 75% under the Pim van Vliet Multi-Factor Investor model, which prioritizes low volatility, strong momentum, and high net payout yield. This score falls below the 80% threshold necessary to indicate strategic interest and results in a final 'FAIL' rank within this specific quantitative framework. While TMO, a large-cap medical supplies company, successfully passes the model's criteria for market capitalization and low standard deviation, it registers only 'NEUTRAL' on both its twelve-minus-one-month momentum and its net payout yield. This mixed assessment, corroborated by a mildly negative sentiment score of -0.3 for the ticker, suggests that while the stock exhibits desirable defensive, low-risk characteristics, it currently lacks the positive momentum and shareholder return profile required for a buy signal under this conservative factor strategy.

Key Decisions for Investors

• Investors following quantitative, multi-factor strategies that equally weight momentum and yield alongside volatility should note TMO's failure to meet the required criteria.
• For those prioritizing capital stability, TMO's passing grade on low volatility is a positive signal, but the neutral momentum score suggests a potential lack of near-term price appreciation catalysts.
• Consider monitoring TMO for an inflection in its momentum metrics or an enhancement in its capital return policy, as these are the primary factors currently constraining its rating in this model.